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Background: In 2005, CDC began the Diabetes Primary Prevention Initiative Interventions Focus
Area (DPPI-IFA), which funded fıve state Diabetes Prevention and Control Programs (DPCPs) to
translate diabetes primary prevention trials into real-world settings by developing and implementing
a framework for state-level diabetes primary prevention.

Purpose: The purpose of this case study, conducted in 2007, was to describe DPPI-IFA implementation, including facilitators and challenges to the initiative.
Methods: Case studies of the fıve DPCPs in the DPPI-IFA involving site visits with key informant
interviews of state staff and partners and archival record collection.

Results: Partners recruited for DPPI-IFA activities included local or state public health agencies
(three of fıve DPCPs); regional or state nonprofıt organizations (fıve DPCPs); businesses or employers (three DPCPs); and healthcare organizations (four DPCPs). The DPCPs implemented a variety of
interventions in three main domains: diabetes primary prevention and prediabetes awareness,
screening activities and lifestyle interventions, and prediabetes-related health policy efforts. Preliminary outcomes are described at the individual and organization/partnership levels. Results suggest
the importance of utilizing preexisting partnerships to extend work into diabetes prevention, providing even small amounts of funding to partners, and prior program planning for diabetes prevention. Challenges for the DPPI-IFA included recruiting participants, establishing links with providers
to obtain diagnostic testing for people screened for prediabetes, and offering a lifestyle intervention.
Conclusions: The DPPI-IFA represents a unique effort by state public health programs in the
translation of diabetes primary prevention trials into real-world settings. The experiences of the
DPPI-IFA programs offer valuable lessons for future community-based diabetes prevention initiatives, especially regarding the need to strengthen clinical– community partnerships for referral of
people with prediabetes to evidence-based lifestyle programs.
(Am J Prev Med 2010;39(3):235–242) © 2010 American Journal of Preventive Medicine

Introduction

I

n the U.S., nearly 30% of adults have prediabetes
(defıned as impaired fasting glucose [IFG] or impaired glucose tolerance [IGT]).1 People with these
conditions have a fıve to 15 times greater risk of developing diabetes than people with normal blood glucose.2
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Importantly, there is fırm consensus that intensive lifestyle interventions can delay or prevent the onset of diabetes in people with prediabetes3–7 and that screening
and lifestyle interventions are cost effective.6 –9
Preventing the burden of diabetes by detecting and
intervening in people with prediabetes, however, requires
translation of clinical trials into real-world settings.10 –12
Public health agencies play an important role in the translation of diabetes prevention trials through a variety of
mechanisms, including promoting the adoption of
screening guidelines in healthcare settings,13 developing
community-based interventions, and linking providers
to existing interventions. Yet “many public health areas
relevant to diabetes have been relatively underexplored
and understudied.”10
Am J Prev Med 2010;39(3)235–242 235
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In 2005, the CDC’s Division of Diabetes Translation
began the Diabetes Primary Prevention Initiative (DPPI),
which built on previous public health diabetes prevention
projects.14,15 The Interventions Focus Area (IFA) component of the DPPI funded fıve state Diabetes and Prevention Control Programs (DPCPs) in California, Massachusetts, Michigan, Minnesota, and Washington to
develop, implement, and disseminate a framework for
state-level primary prevention programs targeting people
with prediabetes. States were given maximum flexibility
to identify and implement interventions across the broad
spectrum of activities normally conducted by DPCPs
(health communications, health systems interventions,
and community interventions and policy initiatives). At
the same time that DPCPs piloted their own state-based
initiatives, they also worked together in an ongoing fashion to develop a framework and other materials that
would guide other DPCPs in future efforts.
In 2007, the CDC and the Agency for Healthcare Research and Quality (AHRQ) contracted with RTI International to develop a descriptive case study of the fıve
states participating in DPPI-IFA. The purpose of the
present study was to describe the implementation of diabetes primary prevention programs in the fıve states, with
an explicit intent to identify and disseminate lessons
learned, resources, and tools to inform future efforts of
CDC, the additional 54 DPCPs in all states and territories,
and other public health and clinical stakeholders. This
manuscript describes the key fındings of the case study,
provides recommendations to CDC and DPCPs for further efforts, and provides recommendations to other clinical
or public health organizations attempting to translate the
diabetes prevention clinical trials into real-world settings.

Methods
The case study design was influenced by CDC’s “Framework for
Program Evaluation in Public Health”16 and key qualitative research authors.17,18 The work was also guided by a Steering Group
of representatives from CDC, AHRQ, and state DPCPs who focused the case study; gave extensive input to the design of case
study questions (Table 1) and methods; and reviewed the fınal case
study report. RTI’s IRB reviewed the proposed work and determined it to be exempt from review.
RTI reviewed program documents from each state, developed
and completed state-specifıc Program Summary Forms (PSF), and
conducted face-to-face and telephone interviews. From July
through September 2007, RTI conducted fıve 2-day site visits, with
a total of 29 interviews involving 57 people (14 DPCP staff, 6 other
state health department staff, and 37 partners). These site visits
included key informant interviews and additional archival record
collection. The interview guides were developed based on the case
study questions and consisted of open-ended, semistructured
questions. A combined purposive and snowball sampling strategy
was used to identify key informants beyond program staff with a

Table 1. DPPI-IFA case study questions
Level
Structure

Overarching questions
What are the intervention designs?
Are interventions consistent with best
practices and available evidence?
What types of support were most helpful to
the pilot states in facilitating
implementation of this program?
What have been the resources needed for
planning and implementing the program?
What are the states doing to institutionalize/
sustain the programs?

Process

How do the programs recruit and retain
partners?
What are partners doing to meet the DPPI
objectives?
How do the programs involve partners once
they are on board?
What tools have been developed or used by
states?

Outcome

What are the programs accomplishing?
What are accomplishments at the participant
level?
What are the accomplishments at the
community/organizational level?

DPPI-IFA, Diabetes Primary Prevention Initiative Interventions Focus
Area

maximum of 12 interviews per site visit, in groups no larger than
three people. State DPCPs were given two opportunities to provide
updated information to capture work conducted since the original
data collection in summer 2007, including 5 additional interviews
with DPCP staff in April and May of 2008.
Two separate analyses—individual case studies and a cross-site
case study—were conducted. Because the case study was largely
descriptive in nature, extensive a priori coding structure was not
used; rather, data were analyzed around case study questions.
Where appropriate, common themes were identifıed and used as
loosely defıned codes both within and across states. The analyses
included an in-depth review of the PSF, annual budgets, program
documents, and notes and recordings of each interview. After
analyses were completed and a site summary was drafted, each case
study team member reviewed the summary for accuracy. For the
cross-site case study, results are organized around fıve major areas:
partnerships, interventions, outcomes, facilitators, and challenges.

Results
Description of the Partners and Partnerships
Central to DPPI–IFA activities was identifıcation of capable partners and establishment and maintenance of
strong partnerships (Table 2). Three of fıve DPCPs partnered with local or state public health agencies, all fıve
www.ajpm-online.net
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Table 2. Primary and secondary DPPI-IFA partners, by funded state
DPPI-IFA state
California

Massachusetts

Michigan

Minnesota

Washington

Intervention description

Partners

Worksite screening and lifestyle
interventions with a primary partner (a
healthcare system and its associated
foundation) and two additional
employers

Healthcare system and its associated foundation
Employers:
Newspaper
Bank
Healthcare system

Clinic-based screening in a healthcare
system

Healthcare system and its associated foundation

Worksite screening and lifestyle
intervention for staff employed at a
local manufacturing facility in
conjunction with a community-based
diabetes nonprofit organization

Community-based diabetes nonprofit organization
Employer: lighting manufacturer
Hospital

Trainings for employers on worksite health
improvement

A regional worksite health improvement initiative,
including employers and other state agencies

Pilot program in a local health department
WISEWOMAN program implementing
diabetes and prediabetes screening
and lifestyle intervention

Michigan WISEWOMAN program
A local health department WISEWOMAN program

Pilot screening and lifestyle intervention
program involving one local health
department WISEWOMAN program
and a local YMCA

A local health department WISEWOMAN program
A local YMCA

A training for WIC providers on gestational
diabetes and development of nutrition
care plans for these clients

Michigan WIC program

Support for a regional diabetes initiative

Regional diabetes initiative (led by a health plan
and a healthcare system)

A screening program in community
locations led by a regional diabetes
outreach network

TIPDON

Support for the development and release
of statewide prediabetes screening
and treatment guidelines

Statewide diabetes steering committee
Statewide clinical guideline development
organization

Newspaper and TV media to increase
prediabetes awareness

Minnesota Diabetes Collaborative
Statewide diabetes steering committee
State public health genomics program
American Diabetes Association (Minnesota)

A multisite screening and lifestyle
intervention (I CAN Prevent Diabetes)
involving local Steps programs,
clinics, and YMCAs

Steps to a Healthier Minnesota (and local Steps
programs in Rochester, St. Paul, Willmar, and
Minneapolis)
Four clinics
Two YMCAs and one parks and recreation center

A screening program in a rural hospital
district for prediabetes incorporated
into an existing health risk
assessment for county employees

A rural hospital district

A collaboration with REACH organizations
in Seattle to conduct screenings in
three community-based health clinics
or organizations, all of which serve
racial and ethnic minorities

REACH Seattle
Three community-based clinical/health
organizations

DPCPs, Diabetes Prevention and Control Programs; DPPI-IFA, Diabetes Primary Prevention Initiative Interventions Focus Area; I CAN Prevent
Diabetes, Individuals and Communities Acting Now to Prevent Diabetes; REACH, racial and ethnic approaches to community health; TIPDON,
Northern Michigan’s Diabetes Outreach Network; WIC, U.S. Department of Agriculture’s Special Supplemental Nutrition Program for Women,
Infants, and Children; WISEWOMAN, Well-Integrated Screening and Evaluation for Women Across the Nation
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DPCPs partnered with regional or state nonprofıt organizations, three partnered with businesses or employers,
and four partnered with healthcare organizations. Primary partners worked directly with DPCPs on design or
implementation of interventions, whereas secondary
partners worked closely with primary partners but had
little direct interaction with DPCPs. For example, in
one state, the health department partnered with a local
community-based diabetes organization, which in turn
partnered with a hospital and a business to conduct a
worksite screening.
Across all fıve states, three key themes emerged regarding reasons state DPCPs recruited partners for this work:
previous experience or work with DPCP or DPCP staff,
access to target audience, and previous experience in the
area of intervention. Almost all DPPI-IFA states utilized
existing organizational or personal relationships to identify potential partners for implementation of their DPPIIFA interventions. In many cases, DPCPs were able to
capitalize on their relationships with other state health
department programs to integrate diabetes primary prevention and prediabetes screening into other areas of
work. Many partners were selected because they provided
access to high-risk target groups; for example, WellIntegrated Screening and Evaluation of Women Across
the Nation (WISEWOMAN); Women, Infants, and Children (WIC); and Racial and Ethnic Approaches to Community Health (REACH).
Partners’ reasons for participating included that the
DPPI-IFA interventions were in line with their organizational priorities and were a natural fıt with their organizations’ existing work. Having even relatively modest
resources available was enough for several DPCPs and
organizations to initiate a partnership.

Description of the Interventions
The DPCPs implemented a variety of interventions in
three main domains: diabetes primary prevention and
prediabetes awareness, screening activities and lifestyle
interventions, and prediabetes-related health policy.
Diabetes primary prevention and prediabetes awareness interventions. Educating and raising awareness of
prediabetes was a priority for many programs; the fıve
DPCPs implemented fıve interventions in provider
awareness and three in public awareness. Educational
activities were conducted for providers as part of some
screening programs to prepare them to diagnose and
treat individuals with prediabetes identifıed by the community-based screening, and in one state a statewide
educational training on gestational diabetes and nutrition care plan materials were developed for WIC providers. For the general population, another state conducted

several awareness-raising campaigns around family history of diabetes as a risk factor for diabetes and diabetes
primary prevention.
Screening activities and lifestyle interventions. All
fıve DPCPs implemented some type of screening component for their DPPI-IFA intervention, with three worksite
interventions, three health system interventions, two interventions in health departments, and four in other settings. One feature of the DPPI-IFA was that screening
programs generally took place in a community or nonclinical setting, diagnosis took place in a provider’s
offıce or another clinical setting, and interventions
were placed once again in the community. This necessitated linkages and information flow between the public health/community organizations and clinical providers. Community-based screenings took place in health
fairs and other community settings, such as Laundromats, food pantries, and free clinics. Another state implemented two screening pilots in local health department
settings through their existing WISEWOMAN program.
Finally, two states implemented screening in providers’
offıces, either in a network of clinical sites in partnership
with local Steps to a HealthierUS programs or within a
healthcare system.
The linkages between screening activities outside clinical settings and a formal diagnosis of prediabetes in a
clinical setting varied signifıcantly across interventions.
Importantly, DPCPs were almost universally aware that
having a referral source for people was critical before
implementing a community-based screening intervention. Resources and strategies to accomplish this varied
greatly across locations; screened participants in one
community-based program were told to visit their primary care provider for diagnosis, whereas participants in
a worksite intervention had access to a clinical team and
“in-house” oral glucose tolerance testing (OGTT). Other
interventions relied on existing referral networks, which
at times were strengthened by activities of the DPCP or
partner staff.
In the majority of screening interventions, OGTT,
conducted in a provider’s offıce, was recommended as the
diagnostic test of choice. However, screening programs
used a variety of tests to identify people at high risk for
prediabetes and requiring in-offıce, OGTT diagnosis.
These included the ADA paper risk test, a paper screen or
computer algorithm using National Diabetes Education
Program (NDEP) criteria for prediabetes screening, random capillary glucose tests, and fasting capillary glucose
tests. Three of the fıve states had developed a formalized,
documented screening algorithm. Most states acknowledged the importance of tracking and follow-up of individuals screened; two states tracked people screened and
www.ajpm-online.net
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conducted follow-up, one using a paper system and one a
computer database.
Most of the screening activities were paired with lifestyle interventions for those identifıed as high risk for or
having prediabetes. Interventions were offered at worksites; in community settings; at YMCAs; and, for one
healthcare system initiative, as part of their weight management program. Almost all the interventions were described as being adapted from the Diabetes Primary Prevention (DPP) curriculum.3,4 This tailoring of the DPP
curriculum resulted in a shorter (hours and sessions)
treatment intervention. In addition to health education in
a group setting, features of the interventions included
one-on-one sessions with a lifestyle coach, weekly weighins, or a free 4-month membership to a local gym. The
number of contact hours per participant ranged from one
visit to 16 hours. Most interventions were free for the
participants. Although designed for people with prediabetes, the lifestyle interventions in the three states that
had results at the time of data collection each included
participants either whose status was not known or who
were known to not have prediabetes.
Prediabetes-related health policy. Across the fıve
DPCPs, there were three health policy interventions in
health systems, two in health departments, and three in
other settings. One state worked extensively in diabetesrelated health policy, by partnering with a state-based clinical guideline–making body of medical groups, hospitals,
and health plans to strengthen references to prediabetes
within the context of two existing guidelines and to contribute to a new primary prevention of chronic disease guideline. In another state, policy-level work included institutionalizing diabetes and prediabetes screening into the
WISEWOMAN program and working to have prediabetes detection activities included in a regional diabetes
initiative led by a health plan and healthcare system.

Preliminary Outcomes of the Interventions
The purpose of the present case study was descriptive, not
evaluative, and a description of results relies on the evaluations conducted by the DPCPs as well as information
collected in the case study interviews. Several states collected process and impact measures, whereas others were
less engaged in evaluation activities. In general, relatively
little data were available on the implementation or outcomes of activities other than the screenings for
prediabetes.
Organizational and community level. Across the state
DPCPs, there is evidence that some interventions have
been institutionalized and will continue after funding
ends. These include screening and lifestyle interventions
incorporated in one state’s WISEWOMAN program afSeptember 2010
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ter a successful pilot in one county, the WIC nutrition
care plan incorporated into one state’s manual and standard protocols, and the prediabetes screening that was
incorporated into a countywide health promotion campaign. The clinical guidelines in one state, expanded to
incorporate prediabetes, also represent a major potential
policy force.
Some evidence suggests that prediabetes programming
has become institutionalized within the DPCPs and will
continue even without future dedicated funding. An additional outcome of note is the enhanced expertise or
capacity of DPCPs and partners to work in prediabetes or
conduct specifıc interventions.
Individual level. Summarizing individual-level outcome results of the DPPI-IFA is challenging because
data were unavailable or incomplete at the time of data
collection and because different screening and diagnosis strategies were used across sites. This paper summarizes available data from three worksite interventions in two states, the WISEWOMAN screening pilot
in a third state, and community-based screening initiatives in a fourth.
Reach. The worksite interventions had potential to

reach large numbers of people (from 600 to 6,000); the
interventions did reach from 1% to 18% of employees.
The WISEWOMAN pilot had a potential reach of 250
participants. The community-based screenings had an
unknown number of potential participants.
Yield. In one state with two different worksite screen-

ings, more than 80% of people were classifıed as at risk
and recommended for OGTT testing based on NDEP
criteria. In the second of these screenings, approximately
15% of people referred to OGTT were ultimately diagnosed with prediabetes. In two other states, which used
capillary fasting tests, approximately one quarter to one
third of people screened had a blood glucose level over the
cutoff of 100 mg/dL. Unfortunately, no additional data
are available on the diagnoses (yield) of prediabetes from
these groups.
Enrollment in interventions. It is not possible to assess
whether enrollment of people with prediabetes into the
interventions was successful, because interventions were
generally open to people who signed up for screening,
regardless of their risk status or screening results, and
because of the limitations of the tracking systems employed. In one state, 80% of those referred for the intervention did enroll.
Intervention completion. Two states reported data on
intervention completion, reporting high levels (87% and
95%).

240

Porterfıeld et al / Am J Prev Med 2010;39(3):235–242

Outcomes of the interventions. The screening pro-

grams that included a lifestyle intervention resulted in
modest, but potentially meaningful, weight loss. One intervention reported an average weight loss of 3.6% (n⫽14
people); the second reported an average weight loss of
4.3% (n⫽14); and the third reported an average weight
loss of 0.1% (n⫽33).

Facilitators of Success
Several respondents commented that utilizing existing
partnerships was integral to the implementation of
interventions. Often DPCPs developed strong working
relationships with new partners; elements that made
these new relationships effective include identifying
capable lead people within the partner organization
and having a common organizational goal to address
prediabetes.
An additional facilitator of success reported by several DPCPs was the ability to provide even minimal
funding to partners to implement activities. Finally,
three states had participated in previous diabetes prevention
planning work,14,15 which helped them develop ideas for
diabetes primary prevention projects as part of the
DPPI-IFA.

Challenges
Although all DPPI-IFA DPCPs and partners described
their work with DPPI-IFA as a success, they also acknowledged many challenges. Challenges specifıc to the
DPPI-IFA were the level of DPPI-IFA funding to DPCPs;
the nature of the funding (uncertain levels of funding
year-to-year); and the tight timeline within which interventions were to be implemented.
Other challenges are generalizable to communitybased diabetes prevention programs. In the screening
phase of interventions, the variety of screening tests available and slightly varying published algorithms13,19 presented a challenge for DPCPs and partners. States reported
spending a substantial amount of time investigating various tests and designing screening protocols, which decreased the time available to identify or develop lifestyle
intervention programs. Also, recruitment of participants
was a challenge for several states, and worksites presented
unique implementation challenges. Both states with
worksite interventions needed to develop strategies that
would allow for inclusion of participants working different shifts, while not disrupting productivity. Finally, establishing strong links between the public health or community organizations and primary care providers,
ensuring that referral appointments were kept, and obtaining diagnostic test results were notable challenges for
several states. Intervention staff received diagnostic in-

formation for between 3% and 100% of patients. This
indicates suboptimal integration in some cases between
the primary care delivery system and public health.
In the intervention phase, implementing the DPP curriculum as designed was too burdensome, but two states
noted that adapting the DPP curriculum was also a challenge in terms of time and resources required. Programs
also found it challenging to identify enough people with a
diagnosis of prediabetes to fıll capacity in the lifestyle
interventions because of the tight timeline, low numbers
of people recruited, and delays in getting reports back
from providers. As a result, people with an unknown
status or who were known to not have prediabetes were
enrolled in the classes.
A fınal challenge related to the technical aspects of
tracking participants and the need for data systems. All
programs did follow lifestyle intervention participants,
although not all programs tracked screened participants.
Programs commented that some partner staff lacked experience with data collection or computer skills necessary
to maintain the data.

Discussion
For the past 3 years, the DPPI-IFA has challenged state
DPCPs to develop novel interventions in diabetes primary prevention in order to translate research fındings of
clinical trials into real-world settings. The current case
study was designed to provide a midcourse snapshot of
these pilot interventions, their implementation, and early
outcomes, and to inform CDC and future diabetes primary prevention efforts by other DPCPs.
The major limitation of the present case study is that it
was conducted while DPCPs were still in the implementation phase of their interventions. Thus, it cannot be
considered a fınal description of their work. In addition,
the current case study was not intended as an evaluation.
Any fındings or recommendations that extend beyond a
description of the fıve state interventions deserve further
exploration.
Although each DPCP in the DPPI-IFA tackled only
one of a few interventions, together the fıve DPCPs contributed to policy, organizational, and individual change.
In addition to the individual successes of each state, as a
pilot initiative, the DPPI-IFA met its goal of furthering
the translation of clinical trials in diabetes primary prevention to community-based health and public health
settings. The present case study complements other reports emerging from community-based projects20 –22; the
DPPI-IFA is unique, however, in terms of having state
public health entities in the role of disseminators or facilitators of such projects.
www.ajpm-online.net
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Table 3. Recommendations for funders, public health programs, and other stakeholders
CDC or other funders

Provide sustained and sufficient funding.
Provide sufficient time for planning and implementation.
Provide appropriate technical assistance on screening protocols and tests for identifying
people at risk for prediabetes and diabetes in a community-based screening.
Conduct a comprehensive evaluation at the end of the DPPI-IFA, including a costeffectiveness analysis of clinical interventions and an evaluation of the health policy
and awareness interventions.
Reconsider the feasibility of screening programs taking place in community settings.

DPCPs or other public health
programs

Maximize existing relationships when identifying primary prevention partners.
For screening and lifestyle interventions:
Consider a prolonged awareness phase prior to recruitment.
Evaluate and adopt existing algorithms or protocols.
Allocate sufficient staff and resources for tracking and follow-up of participants.
Ensure clinical referrals and a mechanism to get diagnostic information in a timely fashion.
Consider offering an educational intervention for referral physicians.
Adopt existing intervention curriculum if possible.
Track people recruited and screened; adopt existing data systems for tracking and
evaluation.
Strengthen evaluation by involving appropriate staff (for DPCPs, an epidemiologist or
evaluator).
Recognize that partners may need assistance with developing or using data collection
systems.
Look for potential policy or health system interventions that can complement or facilitate
clinical interventions.

Other partners/stakeholders

Recognize the important contribution of local networks of organizations and access to
secondary partners that will aid diabetes primary prevention initiatives.
Seek necessary technical assistance regarding data systems, tracking, and evaluation.

DPCPs, Diabetes Prevention and Control Programs; DPPI-IFA, Diabetes Primary Prevention Initiative Interventions Focus Area

The DPPI-IFA illustrates many of the challenges previously described in translating diabetes prevention science into public health practice. These include deciding
on the target population for intervention and the screening tests to be used to identify them; integrating healthcare and public health systems; designing the lifestyle
interventions, including who should deliver them and
where they should occur; understanding the need for
interventions to be intensive and sustained in nature; and
determining who should pay.11,15,23,24 The DPPI-IFA
also demonstrates the challenges of establishing effective
linkages between public health or community organizations and primary care.25,26
The specifıc challenges of the DPPI-IFA programs offer valuable lessons in terms of recommendations for
CDC or other funders, DPCPs or other public health
programs attempting to translate clinical trials into realworld settings, and other partners or stakeholders (Table
3). For funders such as CDC, it is critical to provide
suffıcient and sustained funding and to provide suffıcient
technical assistance, in the case of the DPPI-IFA to help
grantees to understand and translate technical aspects of
community-based screening (which tests to use, how to
track participants) and lifestyle interventions (how to
adapt the DPP curriculum).
For DPCPs and other public health programs, there are
numerous lessons learned from the variety of clinical
September 2010

interventions of the DPPI-IFA, which address increasing
reach of the interventions (e.g., implementing prolonged
educational phases prior to recruitment); increasing
quality of the screening (e.g., adopting existing protocols); increasing the yield of screening (e.g., ensuring
linkages to providers for diagnostic screening, tracking
participants); and strengthening evaluation. Finally, an
important lesson learned from this initiative is that although utilizing partners and networks of organizations
to implement the varied components of these interventions is necessary, one must recognize and address that
partners may have varying levels of knowledge about
prediabetes, screening and lifestyle interventions, and
systems necessary to conduct evaluation. The overall lack
of outcome data available at the time of this case study
highlights an important and potential gap; future efforts
must prioritize measurement of effectiveness and ideally
cost effectiveness if a case is to be made to disseminate
diabetes prevention programs widely.
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